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Case Report
Bilateral Serous Retinal Detachment as a Presenting Sign of 
Acute Lymphoblastic Leukemia
Jinseon Kim, Woohyok Chang, Min Sagong
Department of Ophthalmology, Yeungnam University College of Medicine, Daegu, Korea
We present a case of bilateral serous retinal detachment (SRD) as a presenting sign of Philadelphia chromo-
some-positive acute lymphoblastic leukemia (Ph
+ ALL). A 45-year-old woman presented with decreased vision and 
was found to have bilateral serous retinal detachment. Peripheral blood smears revealed leukocytosis of 
53.9x10
3/µL with 64.6% lymphoblasts. A bone marrow aspirate revealed the presence of lymphoblasts. Cytogenetic 
and molecular genetic analysis detected a reciprocal translocation between chromosome 9 and 22, t(9;22) 
(q34;q11). A diagnosis of Ph
+ ALL was made. Following systemic chemotherapy, the bilateral SRD resolved com-
pletely with full recovery of vision. The sudden appearance of SRD should raise suspicion for leukemia. Prompt 
recognition of this disease is important for early systemic treatment and restoration of visual function.
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Ocular involvement is common in acute leukemia; it has 
been reported to occur in up to 90% of patients with this disease 
[1]. Typical ocular manifestations of leukemia are round or 
flame-shaped hemorrhages with a white component, intra-
retinal hemorrhages, and cotton wool spots, comprising 
what is called leukemic retinopathy. Serous retinal detach-
ment (SRD) is a less common ocular manifestation of leu-
kemia [1-3].
Several studies have reported serous macular detachment 
in lymphoproliferative disorders, but not as an initial 
symptom. In the majority of reported cases, the systemic 
disease had been diagnosed prior to the development of ocular 
symptoms [4-6]. Furthermore, reports of patients with acute 
lymphoblastic leukemia presenting with visual symptoms 
are rare.
We report a patient with Philadelphia chromosome-positive 
acute lymphoblastic leukemia (Ph
+ ALL) who presented 
with bilateral SRD as the initial sign of leukemia. This is the 
first such reported case in Korea.
Case Report 
A 45-year-old woman presented with a 10-day history of 
visual disturbance and bilateral central scotoma. This had 
been preceded by a one-month history of headache. Her cor-
rected visual acuity was 0.2 in the right eye and 0.8 in the left 
eye. Slit lamp examination revealed no obvious inflammation 
in the anterior chamber or vitreous. Fundus examination of 
both eyes showed bilateral SRD in the posterior pole (Fig. 
1A). Fluorescein angiography of both eyes showed multi-
focal hyperfluorescence beneath the detachment in the early 
phase and diffuse subretinal accumulation of fluorescein in 
the late phase (Fig. 1B). Stratus optical coherence tomography 
(OCT) showed serous retinal detachment with increased 
reflectivity in the choroid layers of both eyes (Fig. 1C). 
Neither neurologic nor dermatologic signs were present on 
physical examination. A blood test revealed leukocytosis of 
53.9×10
3/µL with 64.6% lymphoblasts. The hemoglobin lev-
el was 8.5 gm/dL with a hematocrit of 24.9% and a platelet 
count of 208,000/µL. The clotting screen was within normal 
limits, and the autoantibody screen was negative. Serum urate 
(7.69 mg/dL) and C-reactive protein (0.421 mg/dL) were 
within normal limits. Renal and liver function was normal. 
Based on the ocular findings and hematological abnormal-
ities, the patient was referred to a hematologist, who per-
formed a bone marrow aspiration. Analysis of the aspirate 
showed 94% lymphoblasts, confirming the diagnosis of ALL. 
Cytochemistry and immunophenotyping characterized the Korean J Ophthalmol Vol.24, No.4, 2010
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Fig. 1. (A) Fundus photographs of the right eye (left) and left eye (right) showing bilateral serous retinal detachment in the macula at 
the initial visit. (B) Corresponding fluorescein angiograms show diffuse subretinal accumulation of fluorescein with multifocal hyper-
fluorescent dots. (C) Corresponding optical coherence tomography scans show serous macular detachment.
leukemia as precursor B-cell ALL (L1). Cytogenetic and mo-
lecular genetic analysis showed t(9;22) and minor bcr-abl fusion 
mRNA. The final diagnosis was Ph
+ ALL. Neurological ex-
amination, including lumbar puncture and magnetic resonance 
imaging, showed no involvement of the central nervous 
system. The patient was enrolled in a course of remission in-
duction chemotherapy consisting of intravenous daunorubicin, 
vincristine, and methylprednisolone. One month after in-
duction therapy was initiated, she was treated with con-
solidation chemotherapy consisting of intravenous metho-
trexate, cytarabine and methylprednisolone. Intrathecal me-
thotrexate was administrated as prophylaxis for central 
nervous system involvement. Thereafter, two additional cy-
cles of consolidation chemotherapy were administered. 
Throughout the whole treatment period, the patient was also 
given imatinib once daily to inhibit the activity of the 
bcr-abl fusion protein.
One month after induction therapy was initiated, fundus 
examination, fluorescein angiography, and OCT showed 
complete resolution of the bilateral SRD (Fig. 2). Visual 
acuity had improved to 1.0 in both eyes. Four months after 
the initiation of induction therapy, the patient was in 
complete remission with no ocular symptoms. JS Kim, et al. Bilateral SRD as a Presenting Sign of ALL
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Fig. 2. (A) Fundus photographs of the right eye (left) and left eye (right) showing complete resolution of bilateral serous retinal 
detachment one month after systemic chemotherapy. (B) Corresponding fluorescein angiograms show no subretinal accumulation 
of fluorescein. (C) Corresponding optical coherence tomography scans show nearly normal foveal anatomy. 
Discussion
Ocular changes in leukemia are varied and may involve 
all ocular and adnexal tissues [7]. Most ocular manifestations 
occur secondary to direct leukemic infiltration of the ocular 
structures; hematologic abnormalities such as thrombocyto-
penia, anemia, leucopenia, or hyperviscosity; opportunistic 
infections; or secondary to the treatment of the leukemia it-
self [7,8]. In the fundus, common manifestations include retinal 
vascular sheathing, cotton wool spots, white-centered reti-
nal hemorrhages, nodular infiltrates, and optic nerve head 
infiltrates [1,7,9]. These fundus changes are common dur-
ing the course of the disease; they have been reported to occur 
in up to 90% of patients with leukemia [1]. However, SRD 
has been reported less commonly in the setting of acute leu-
kemia [1-3]. SRD is even less common as the initial finding 
in this disease. In the majority of cases, systemic disease has 
already been diagnosed prior to the development of ocular 
symptoms [4-6]. Most of the previously reported cases of 
ALL with SRD have involved younger patients [6,10,11]. 
Our patient was a 45-year-old woman whose visual impair-
ment was caused by bilateral SRD and led to a diagnosis of Korean J Ophthalmol Vol.24, No.4, 2010
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ALL.
SRD in the setting of leukemia has been reported to be 
shallow in the posterior pole [3,10]. Fluorescein angiographic 
findings in previous studies have demonstrated multifocal 
hyperfluorescence beneath the detachment in the early phase 
and diffuse subretinal accumulation of fluorescein in the late 
phase [3,10]; we noted similar findings in our case. SRD may 
develop as a result of choroidal involvement by leukemic 
cells causing retinal pigment epithelial disturbances or due to 
incompetence of the outer blood-retinal barrier inducing reti-
nal pigment epithelial changes [3,12].
The differential diagnosis of SRD includes Harada's syn-
drome, central serous choroidopathy, uveal effusion syndrome, 
age-related macular degeneration, choroidal hemangioma, 
and metastatic neoplasm. Bilateral SRD and multifocal hy-
perfluorescence beneath the detachment in the early phase of 
fluorescein angiography would support Harada's syndrome 
as the most likely diagnosis. However, our case showed no 
inflammatory reaction in the anterior chamber or vitreous. 
Furthermore, the absence of neurologic and dermatologic 
signs, such as dysacusis, vitiligo, and poliosis, is not con-
sistent with Harada's syndrome. 
Intraocular manifestations of leukemia are not usually 
treated directly. Systemic chemotherapy is recommended 
first. When definite leukemic infiltrates fail to respond 
promptly to chemotherapy, ocular radiation is implemented 
[1]. In our case, the patient received only systemic chemo-
therapy, and the SRD resolved completely with full recovery 
of visual acuity. This suggests that leukemic cells had in-
filtrated into the choroid in the area of the SRD. Therefore, 
we assume that the SRD was a manifestation of ALL. This 
also suggests that systemic chemotherapy alone can preserve 
visual acuity if performed early. 
Our patient had Ph
+ ALL. Recent advances in therapy 
have resulted in better survival for ALL patients. However, 
older age and specific cytogenetic abnormalities, such as 
the Philadelphia chromosome, a reciprocal translocation 
between chromosome 9 and 22, t(9;22)(q34;q11), are ad-
verse prognostic factors in ALL [13].
 Therefore, early diag-
nosis and appropriate treatment are essential for securing a 
favorable prognosis, especially in high-risk ALL patients. 
Our case illustrates that prompt treatment after diagnosis, 
even in a patient with Ph
+ ALL, can result in complete reso-
lution of SRD and allow for full restoration of visual 
function.
In conclusion, bilateral SRD may be the first sign of ALL. 
Thus, ophthalmologists should consider a thorough systemic 
evaluation for leukemia in patients with sudden SRD. 
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